Clinical Trial Update: Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda).

View source ↗

Summary

This clinical trial update reports on evaluating T-cell immune responses after vaccination with Takeda's attenuated tetravalent dengue vaccine, with the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• TAK-003 (attenuated tetravalent dengue vaccine)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Dengue | Status: ACTIVE_NOT_RECRUITING